证券代码：301261 证券简称：恒工精密 公告编号：2025-026 河北恒工精密装备股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 河北恒工精密装备股份有限公司（以下简称"公司"）于 2025 年 8 月 20 日分别召开第二届董事会第十次会议、第二届监事会第十次会议，审议通过了《关 于使用暂时闲置的募集资金进行现金管理的议案》。因募集资金投入需要根据项 目建设的实际进度进行逐步投入，为了提高募集资金使用效率，在保证不影响募 投项目建设和募集资金正常使用的情况下，同意公司使用额度不超过 0.7 亿元人 民币的暂时闲置募集资金进行现金管理，该额度可以在董事会审议通过之日起 人民币额度同时失效。现将相关事项公告如下： 一、本次公开发行股票募集资金的基本情况 经中国证券监督管理委员会《关于同意河北恒工精密装备股份有限公司首次 公开发行股票注册的批复》（证监许可〔2023〕617 号）同意注册，恒工精密 首次公开发行新股 21,972,549 股，发行价格为 36.90 元/股，募集资金总额为 司实际收到募集资金 739,454,012.73 元，前 ...

中信证券股份有限公司 关于河北恒工精密装备股份有限公司 使用暂时闲置的募集资金进行现金管理的核查意见 河北恒工精密装备股份有限公司（以下简称"公司"）于 2025 年 8 月 20 日 分别召开第二届董事会第十次会议、第二届监事会第十次会议，审议通过了《关 于使用暂时闲置的募集资金进行现金管理的议案》。因募集资金投入需要根据项 目建设的实际进度进行逐步投入，为了提高募集资金使用效率，在保证不影响募 投项目建设和募集资金正常使用的情况下，同意公司使用额度不超过 0.7 亿元人 民币的暂时闲置募集资金进行现金管理，该额度可以在董事会审议通过之日起 人民币额度同时失效。 中信证券股份有限公司（以下简称"中信证券"或"保荐机构"）作为公司 首次公开发行股票并在创业板上市持续督导保荐机构，根据《证券发行上市保荐 业务管理办法》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市 公司自律监管指引第 13 号——保荐业务》《深圳证券交易所上市公司自律监管 指引第 2 号——创业板上市公司规范运作》等有关规定，对使用暂时闲置的募集 资金进行现金管理的事项进行了核查，具体情况如下： 一、本次公开发行股票募集资金的基本情况 ...

Core Points - The company, CanSino Biologics, has approved the use of temporarily idle raised funds for cash management, with a maximum amount of 340 million yuan, ensuring that it does not affect the implementation of fundraising projects [7][10][20] - The company reported a total fundraising amount of 5.200 billion yuan from its initial public offering, with a net amount of approximately 4.979 billion yuan after deducting issuance costs [25][26] - As of June 30, 2025, the company has utilized approximately 4.722 billion yuan of the raised funds, leaving a balance of about 261.87 million yuan [26][30] Financial Data - The total amount raised from the public offering was 5.200 billion yuan, with a net amount of 4.979 billion yuan after costs [25][26] - The company has generated approximately 240.82 million yuan in interest income and cash management income from the raised funds [26] - The company has used 4.721 billion yuan of the raised funds, with 294.5 million yuan allocated for cash management [26][34] Fund Management - The company has established a fundraising management system to ensure the proper use and supervision of the raised funds [27] - A tripartite supervision agreement has been signed with the underwriter and banks to manage the raised funds [28] - The company plans to invest temporarily idle funds in safe, liquid, and guaranteed investment products, including structured deposits and wealth management products [11][20] Project Updates - The company has made changes to some fundraising projects, reallocating funds to the CanSino Innovation Vaccine Industrial Park project [38][39] - The expected completion date for the Innovation Vaccine Industrial Park project has been postponed from December 2024 to December 2026 [41] - There are no remaining unallocated funds from the over-raised capital as of June 30, 2025 [36][42]

财通证券股份有限公司 关于浙江众合科技股份有限公司 使用部分闲置募集资金进行现金管理的核查意见 财通证券股份有限公司（以下简称"财通证券"或"保荐人"）作为浙江众 合科技股份有限公司（以下简称"众合科技"或"公司"）向特定对象发行股票 并主板上市的保荐人，根据《证券发行上市保荐业务管理办法》《上市公司募集 资金监管规则》 《深圳证券交易所股票上市规则》 《深圳证券交易所上市公司自律 监管指引第 1 号——主板上市公司规范运作》等有关法律、法规以及规范性文件 的要求，对众合科技使用部分闲置募集资金进行现金管理事项进行了审慎核查， 具体情况如下： 基于自研芯片的数字孪生工业控制平台 研发及产业化项目 大交通领域数字化关键技术研发及产业 化项目 一、本次募集资金的基本情况 经中国证券监督管理委员会《关于同意浙江众合科技股份有限公司向特定对 象发行股票注册的批复》 （证监许可〔2023〕2810 号）同意注册，公司向特定对 象发行人民币普通股（A 股）130,209,496 股，每股面值为 1.00 元（人民币，币 种 下 同 ）， 发 行 价 格 为 5.25 元 / 股 ， 本 次 发 行 的 募 集 资 金 总 ...

Core Viewpoint - The company plans to utilize part of its idle raised funds, not exceeding RMB 650 million, for cash management to enhance fund efficiency while ensuring the safety and proper use of the raised funds [1][4][6]. Fundraising Overview - The company raised a total of RMB 838.59 million from its initial public offering, with a net amount of RMB 810.66 million after deducting issuance costs [1][2]. - The funds are managed in a dedicated account, adhering to regulatory requirements [1][2]. Fund Utilization Plan - The net amount from the fundraising is RMB 810.66 million, with specific projects planned for investment [2][3]. - The company acknowledges that some of the raised funds may temporarily remain idle due to project timelines [3]. Cash Management Plan - The company intends to invest the idle funds in high-security, liquid, and capital-protected financial products, including but not limited to time deposits and structured deposits [4][6]. - The cash management period will not exceed 12 months from the board's approval date, allowing for rolling use of the funds within the specified limit [3][4]. Impact on Daily Operations - The cash management plan will not affect the company's normal operational cash flow or the execution of investment projects [4][6]. - The strategy aims to generate additional returns on idle funds, benefiting overall company performance and shareholder returns [4][6]. Approval Process - The board of directors approved the cash management proposal on August 15, 2025, without requiring shareholder meeting approval [6][7]. - The proposal complies with relevant regulations and internal management policies [6][7].

Core Viewpoint - The company intends to utilize part of its temporarily idle raised funds for cash management to enhance fund efficiency and increase returns for the company and its shareholders [1][4][6] Summary by Sections 1. Basic Situation of Raised Funds - The company raised a total of RMB 149,880.00 million by issuing 60 million shares at RMB 24.98 per share, with a net amount of RMB 135,810.35 million after deducting various fees [1] - The raised funds have been deposited in a special account approved by the board of directors, and a tripartite supervision agreement has been signed with the sponsor and the supervising bank [1] 2. Basic Situation of Investment Projects - The total planned investment for the projects funded by the raised funds is RMB 132,363.65 million, with an actual investment of RMB 41,233.80 million as of June 30, 2025 [2] 3. Cash Management of Idle Funds - The purpose of cash management is to improve the efficiency of raised funds and ensure that it does not affect project construction or fund safety [3] - The company plans to use up to RMB 9 billion of idle funds for cash management, with a rolling usage within a 12-month period [3] 4. Implementation and Disclosure - The board has authorized the management to make investment decisions within the approved limits and time frame, with the finance department responsible for implementation [4] - The company will comply with relevant regulations for timely information disclosure regarding cash management activities [4] 5. Impact on the Company - The cash management of idle funds is conducted in compliance with laws and regulations, ensuring no impact on project execution or the company's main business [4][6] - This approach is expected to enhance fund efficiency and increase returns for the company and its shareholders [4][6] 6. Opinions from Supervisory Bodies - The supervisory board agrees that the cash management of idle funds will not affect the normal operation of the company or the investment projects, and it aligns with the interests of all shareholders [5][6] - The sponsor has confirmed that the cash management plan has undergone necessary approval processes and complies with relevant regulations [6]

Core Viewpoint - The company, Nanjing Maglev Technology Co., Ltd., intends to continue using temporarily idle raised funds (including oversubscribed funds) for cash management to enhance the efficiency of fund utilization and increase returns for shareholders [1][3][7]. Fundraising Basic Situation - The total amount raised from the initial public offering (IPO) was RMB 586.1234 million, with a net amount of RMB 528.5685 million after deducting issuance costs [1]. - All raised funds have been received as of September 15, 2022, and a tripartite supervision agreement has been signed for the management of these funds [1]. Investment Project Situation - The raised funds are planned to be used entirely for projects related to the company's main business, specifically for the construction of high-efficiency intelligent integrated magnetic levitation fluid equipment, with a total investment of RMB 450 million [2]. Cash Management Plan - The company plans to use up to RMB 300 million of temporarily idle raised funds for cash management, with a validity period of 12 months from the board's approval date [2][4]. - The investment products will include low-risk, high-liquidity options such as structured deposits, agreed deposits, and time deposits [3][4]. Impact on Daily Operations - The cash management will not affect the construction of investment projects or the normal operations of the company, ensuring the safety of the raised funds [5][7]. - The management of idle funds is expected to improve fund utilization efficiency and generate better returns for the company and its shareholders [5][7]. Review and Approval Process - The board of directors and the supervisory board have approved the cash management plan, and it does not require further approval from the shareholders' meeting [5][7]. - The sponsor institution has confirmed that the process complies with relevant regulations and is beneficial for improving fund efficiency and returns [7][8].

证券代码：688392 证券简称：骄成超声 公告编号：2025-041 上海骄成超声波技术股份有限公司 关于增加使用部分暂时闲置募集资金进行现金管理的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 上海骄成超声波技术股份有限公司（以下简称"公司"）于 2025 年 8 月 18 日召开第二届董事会第十次会议，审议通过了《关于增加使用部分暂时闲置募集 资金进行现金管理的议案》，同意公司（含子公司，下同）在确保不影响募集资 金投资项目进展、确保募集资金安全及不影响公司日常经营业务开展的情况下， 增加使用不超过人民币 40,000 万元（含）的暂时闲置募集资金进行现金管理， 额度由原来使用不超过人民币 60,000 万元增加至人民币 100,000 万元（含），用 于购买安全性高、流动性好的投资产品（包括但不限于结构性存款、通知存款、 定期存款、大额存单、协定存款等），使用期限为自第二届董事会第七次会议审 议通过之日起不超过 12 个月。在上述额度及决议有效期内，资金可滚动使用。 董事会授权董事长在上述额度范围和投资期限内行 ...

Core Viewpoint - The company plans to increase the use of temporarily idle raised funds for cash management to enhance fund utilization efficiency and generate additional returns for the company and its shareholders [4][6][8]. Summary by Sections Fundraising Basic Information - The company raised a total of RMB 1,459,190,000.00 from its initial public offering, with a net amount of RMB 1,296,362,184.31 after deducting related expenses [2][3]. Investment Project Overview - The total investment amount for the projects funded by the raised capital is RMB 424,753,400.00 [3]. Previous Cash Management Usage - The company previously approved the use of up to RMB 60,000,000.00 of temporarily idle funds for cash management, focusing on high-safety and high-liquidity investment products [3][5]. Current Cash Management Increase - The company intends to increase the cash management limit to RMB 100,000,000.00, allowing for a maximum of RMB 40,000,000.00 in additional temporarily idle funds for cash management, with a usage period not exceeding 12 months [5][8]. Investment Purpose - The purpose of this cash management is to improve the efficiency of idle funds while ensuring that it does not affect the progress of investment projects or the company's daily operations [4][6]. Investment Products - The company will invest in low-risk, high-liquidity products such as structured deposits, notice deposits, time deposits, large certificates of deposit, and agreement deposits [5][6]. Decision-Making and Implementation - The board of directors has authorized the chairman to make investment decisions within the specified limits and timeframes, with the finance department responsible for implementation [5][6]. Disclosure and Compliance - The company will comply with relevant regulations and ensure timely information disclosure regarding the cash management activities [5][6]. Impact on Daily Operations - The increase in cash management usage is designed to not impact the company's daily operations or the normal implementation of investment projects, aiming to generate additional returns for shareholders [6][8].

国投证券股份有限公司 关于深圳微芯生物科技股份有限公司 继续使用暂时闲置募集资金进行现金管理的核查意见 国投证券股份有限公司（以下简称"国投证券"或"保荐机构"）作为深圳 微芯生物科技股份有限公司（以下简称"微芯生物"或"公司"）首次公开发行 股票并在科创板上市和向不特定对象发行可转换公司债券持续督导的保荐机构， 根据《证券发行上市保荐业务管理办法》《上市公司募集资金监管规则》《上海 证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有关法律、法 规的规定以及《深圳微芯生物科技股份有限公司募集资金管理制度》的相关规定， 对公司使用暂时闲置募集资金进行现金管理事项进行了认真、审慎的核查，并发 表意见如下： （万元） 一、募集资金基本情况 根据中国证券监督管理委员会出具的《关于同意深圳微芯生物科技股份有限 公司首次公开发行股票注册的批复》（证监许可〔2019〕1299 号），公司首次 向社会公众公开发行人民币普通股（A 股）5,000.00 万股，每股面值人民币 1 元， 每股发行价格为人民币 20.43 元，募集资金总额为人民币 102,150.00 万元，扣除 发行费用人民币 7,631.18 万 ...